Gilead data from 53 patients on potential COVID-19 drug 'hopeful'

Experts warn, however, that the results from 53 patients taking Gilead's drug remdesivir under "compassionate use" programs carry a lot of caveats.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.